13
Disease modification in Myelofibrosis
MyelofibrosisAK
Preface
1
Introduction
2
MPN-SAF Total Symptom Score (TSS)
3
Risk Stratification in MF
4
Pulmonary Hypertension in Myeloproliferative Neoplasms
5
JAK inhibitors in Myelofibrosis
6
Pacritinib data
7
prePMF vs ET
8
Anemia in MF
9
JAK inhibitor combination therapies
10
Selinexor in MF
11
Mutant CALR targeted Therapies
12
INCA33989 Phase 1 Clinical Trial Results in Myelofibrosis - ASH 2025 Update
13
Disease modification in Myelofibrosis
14
Transplant in Myelofibrosis
15
Summary
References
13
Disease modification in Myelofibrosis
Code
12
INCA33989 Phase 1 Clinical Trial Results in Myelofibrosis - ASH 2025 Update
14
Transplant in Myelofibrosis
Source Code
---
title:
"Disease modification in Myelofibrosis"
---